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 Over 3 million followers on a health 
promotion Chinese Twitter account 
(Weibo), which broadcasts on a 
range of health topics, including 
immunization, H7N9, and smoking 
cessation. 
 
 In 2012, FETP trainees participated 
in 118 outbreaks ranging from 
cholera to brucellosis. 
 
 From 2011-2012, assessed 
tuberculosis among 900 village 
doctors, an under-served group of 
rural healthcare workers in China. 
 
 From 2009-2013, identified at least 
20 provincial foodborne outbreaks 
using molecular typing methods of 
foodborne infections caused by 
Salmonella  and created a national 
database of strain types. 
 
 
CDC in China 
The Centers for Disease Control and Prevention (CDC) and the 
Chinese government have collaborated on public health priorities that affect China, 
the United States, and the global community for more than 30 years. U.S. CDC 
focuses its China-based work on HIV/AIDS, emerging and re-emerging infectious 
diseases, immunizations, workforce development, non-communicable diseases, 
and laboratory quality and safety. 
 
 
Centers for Disease Control and Prevention 
 
HIV/AIDS  
It has been 10 years since the landmark launch of the China-US CDC collaboration 
on HIV/AIDS. A primary goal of CDC’s HIV work in China has been to control the 
spread of HIV from those already infected. The program focuses technical 
assistance to China on developing evidence-based guidelines and sound technical 
strategies that result in enhancing local capacity in HIV/AIDS surveillance, 
laboratory methods, interventions for hard-to-reach populations, and quality HIV 
care and treatment.  In the next five years, programs will concentrate activities in 
five key provinces and one prefecture with high disease burdens and restricted 
economic resources. The collaboration focuses on developing national HIV/AIDS 
policy, conducting innovative pilot projects and building laboratory and public 
health workforce capacity. Particular attention is focused on most-at-risk 
populations such as men who have sex with men, female sex workers, people who 
inject drugs, and ethnic minorities with high HIV prevalence. The partnership is 
increasingly dedicated to supporting China's role in the international public health 
community through dissemination of scientific information and support to other 
developing countries.  
 
Non-communicable Diseases 
Recognizing the significant public health burden of non-communicable diseases 
(NCDs), an innovative China-US collaboration for NCDs that includes chronic 
disease and injury prevention and control has been developed. Efforts focus on key 
strategic areas and providing capacity building and learning opportunities for both 
China and US CDC. Strategic activities include dietary salt intake reduction to 
prevent high blood pressure and heart disease, tobacco control, injury prevention, 
air quality and human resource capacity building. Efforts in all of these areas are 
strongly supporting implementation of China’s first-ever National NCD Prevention 
and Control Five Year Plan (2011-2015). 
Staffing: 8 U.S. Assignees 
 41 Locally Employed  
 
 
Center for Global Health 
Top 10 Causes of Deaths in China 
 Malignant Neoplasms 28%                 Endocrine, Nutritional & metabolic 
Diseases 3.4% 
 
 Heart Disease        21%  Diseases of the Digestive System 3%  
 Cerebrovascular Disease 11%   Diseases of the Nervous System 1%  
 Diseases of the Respiratory System 
5% 
 Diseases of the Genitourinary 
System 1% 
 
 Injury & Poisoning 3%  Infectious Diseases  0.9%  
Source: http://www.chinacdc.cn/tjsj/gjwstjsj/201206/t20120608_63463.htm, 
China Health Statistics Summary 2012 
 
 
For more information please contact Centers for Disease Control and Prevention: 
CDC-Atlanta  
1600 Clifton Road NE, Atlanta, GA  30333  
Email: cgh@cdc.gov       
Web: www.cdc.gov/global  
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CDC works with Chinese public health officials to eradicate, eliminate, or control 
vaccine preventable diseases through immunization efforts. A CDC expert assigned to 
the WHO China office leads efforts to advise China MOH on strengthening the China 
immunization program and enhancing evidence-based immunization 
recommendations and practices.  Immunization goals include implementing the Polio 
Endgame Strategic Plan, eliminating measles, accelerating control of hepatitis B, and 
providing the scientific evidence-base to promote the inclusion of new vaccines in 
China’s immunization program.  
 
Global Disease Detection (GDD) 
The China-U.S. Collaborative Program on Emerging and Re-emerging Infectious 
Diseases (EID) serves as one of ten GDD Centers. EID’s main role in China is to provide 
assistance to the Chinese Government in outbreak response, pathogen discovery, 
surveillance, laboratory strengthening and quality control, training of public health 
practitioners and researchers, and building networks that enhance collaboration with 
the Chinese Center for Disease Control and Prevention.  GDD includes the following 
programs: 
 
International Emerging Infections Program (IEIP) 
U.S. CDC and China CDC experts work to strengthen public health surveillance, prevent 
transmission of infections, and improve laboratory detection of epidemic-prone 
infectious diseases. This comprehensive approach helps China identify and contain 
infectious disease outbreaks before they spread globally. IEIP-China currently provides 
technical assistance to China CDC to support surveillance systems for severe respiratory 
infections, foodborne infections, healthcare-associated infections, in particular 
tuberculosis, viral hepatitis and vector-borne diseases. 
 
Field Epidemiology Training Program (FETP) 
The Chinese Field Epidemiology Training Program (CFETP), a two-year program, 
strengthens disease surveillance, applied epidemiology, and response capacities 
through a rigorous curriculum and extensive field work experience that is designed to 
train China’s future public health leaders. Two tracks are currently being offered–one 
with a focus on communicable diseases, and second on non-communicable diseases 
that includes chronic diseases, injuries, and environmental health.  
 
Influenza 
For more than 20 years, CDC has supported the Chinese National Influenza Laboratory to monitor seasonal and novel influenza viruses 
with pandemic potential. Now, CDC, China CDC, and the MOH have combined expertise on pandemic influenza preparedness, influen za 
surveillance, and rapid response to prevent, identify, and control influenza.  In addition, CDC is working with Chinese public health leaders 
to gather data and identify domestic scientific evidence to inform Chinese national influenza vaccination policy on expanding  existing 
influenza vaccine programs. In response to H7N9 outbreaks, CDC worked closely with Chinese health authorities to analyze and 
report on surveillance data, share viral specimens, and improve vaccine development capacity. 
 
Strengthening Laboratory Capacity 
CDC assists China in improving the quality of laboratory services at selected national and provincial laboratories with the imple mentation 
of international-based laboratory standards, improving worker safety, and reducing the risk of accidentally releasing harmful substances. 
 
Tuberculosis  
With 1.5 million cases of tuberculosis (TB), China has the second highest burden of TB in the world after India. In 2008, the  GDD Program in 
China incorporated TB into its mission. The objective is to provide strategic technical assistance and training on priority areas for TB 




China at a Glance 
Population:      1,390,000,000 
Per capita income:      $8,390 
Life expectancy at 
birth women/men: 





Population Reference Bureau W orld Population Data 
Sheet, 2011 
 
               
 
